KalVista Pharmaceuticals (KALV)

NASDAQ:KALV

KALV

KalVista Pharmaceuticals

RESEARCH TOOLSreports

Compare KalVista Pharmaceuticals (KALV) vs. Competitors

611 Followers

Comparison Results

KALV

KalVista Pharmaceuticals

$19.39

$993.20M

-37.98

83.97%

7 Buy

0 Hold

0 Sell

Strong Buy

Savara

$5.66

$1.16B

-11.28

114.39%

4 Buy

0 Hold

0 Sell

Strong Buy

Arvinas Holding Company

$10.82

$692.06M

-9.53

63.44%

8 Buy

6 Hold

0 Sell

Moderate Buy

Gossamer Bio

$0.41

$96.11M

-3.72

-47.36%

3 Buy

5 Hold

1 Sell

Hold

Compass Therapeutics

$5.17

$931.05M

-12.74

213.33%

9 Buy

0 Hold

0 Sell

Strong Buy

Bicara Therapeutics Inc.

$21.12

$1.38B

-6.67

108.08%

8 Buy

2 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

KALV vs BCAX

xxxxxxxxxxxxx

Performance Comparison

KALV

KalVista Pharmaceuticals

19.39

7.44

62.26%

SVRA

Savara

5.66

2.76

95.17%

ARVN

Arvinas Holding Company

10.82

3.42

46.22%

GOSS

Gossamer Bio

0.41

-0.40

-49.63%

CMPX

Compass Therapeutics

5.17

3.45

200.58%

BCAX

Bicara Therapeutics Inc.

21.12

9.74

85.59%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >